CBS 2019
CBSMD教育中心
中 文

Percutaneous LAA Occlusion

Abstract

Recommended Article

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Clinical TrialVolume 41, Issue 20, 21 May 2020, Pages 1890–1899

JOURNAL:Eur Heart J. Article Link

Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

H Thiele, T Kurz et al on behalf of the SOLVE-TAVI Investigators. Keywords: self-expandable vs. balloon-expandable valves; RCT

Full Text PDF